The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection.

The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection. Abstract Text:

We report the use of the Novalung interventional Lung Assist extracorporeal carbon dioxide removal device, (Novalung GmbH, Lotzenacker 3, D-72379 Hechingen, Germany) to treat a 46-year-old female with life-threatening bronchospasm secondary to influenza infection. Despite maximal treatment she developed severe hypercapnia and acidosis. The necessity for high inflation pressures led to the development of gross surgical emphysema. Use of the interventional Lung Assist enabled a rapid correction of hypercapnoea and acidosis, allowing a reduction in airway pressures, reducing further barotrauma. Subsequent resolution of the inflammatory process allowed removal of the interventional Lung Assist after 11 days. She was successfully weaned from mechanical ventilation and made a full recovery.

The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Anaesthesia and intensive care

VOLUME: 36

Page Numbers: 579-81

Journal Abbreviation:

ISSN: 0310-057X

DAY: 21

MONTH: Jul

YEAR: 2008

The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 342017

The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection.

AFFILIATION: Department of Critical Care Medicine, Gloucestershire Royal Hospital, Gloucester, United Kingdom.

Country: Australia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Anaesth Intensive Care

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection Related Publications

• A multicenter multidimensional study of some new long-acting neuroleptic drugs. General introduction.
• A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. 3. Celibacy rate and fertility.
• A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. 8. Clinical-electroencephalographic investigation.
• A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. I. Genetic investigation.
• A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. II. Childhood environment and precipitating factors.
• A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. IV. A multidimensional study of personality traits.
• A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Introduction.
• A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. V. Body-build.
• A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. VI. Studies in perception: a) colour-form preference.
• A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. VII. Studies in perception. b) Flicker- and fusion threshold.
• A study of cycloid psychoses.
• A theoretical framework for linking the experience of dysfunctional parental rearing attitudes with manifest psychopathology.
• Averaged evoked responses (aer) in patients with affective disorders.
• Averaged evoked responses, pain measures, and personality variables in patients with depressive disorders.
• Catechol-o-methyltransferase and plasma monoamine oxidase in patients with affective disorders.
• Cerebral functional dominance and memory functions. An analysis of EEG integrated amplitude in depressive psychotics.
• EEG Photically elicited alpha blocking responses in depressive patients before and after convulsive therapy.
• Genetic transmission of depressive psychoses.
• Life events and biological vulnerability: a study of life events and platelet MAO activity in depressed patients.
• Morbidity risk for psychiatric disorders in families of probands with affective disorders divided according to levels of platelet MAO activity.
• Non-psychotic depressive disorders: a ten year follow-up.
• Personality patterns in patients with affective disorders.
• Proteoglycans in the control of tumor growth and metastasis formation.
• Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy.
• Screening for porphyria among psychiatric patients.
• The Capgras syndrome: a case report.
• The early family situation of Hungarian depressed patients.
• The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection.
• [Psychological tolerance problems to complete dentures]
• [The electroencephalogram in mental diseases with endocrine disorders.]